Most medication problems in veterinary medicine do not come from bad doctors.
They come from good clinical decisions running into the realities of drug formulations, species differences, and the way medications actually get used outside the exam room.
A dog gets a formulation that technically works but is nearly impossible for the owner to give. A cat reacts to an excipient no one thought twice about. A dose looks right until you remember the pharmacokinetics in that species are completely different. A prescription moves from the hospital to a pharmacy to a client, and somewhere in that handoff, something small breaks.
None of this is rare. It is daily practice.
For a long time, veterinary medicine absorbed most of this complexity internally. The veterinarian prescribed, dispensed, counseled, and followed the case. Pharmacy, when it showed up, was mostly a product source. That model worked when drug options were limited and expectations were lower.
That is no longer the reality.
We now practice in a world of expanded therapeutics, compounded medications, tighter regulatory oversight, and clients who expect safety and outcomes that look a lot more like human medicine. At the same time, much of what we prescribe, how it is formulated, and how it moves through the system was not built with veterinary patients in mind.
That mismatch shows up everywhere.
Animals differ across species in ways that fundamentally change how drugs are absorbed, distributed, metabolized, and eliminated. Even something as simple as taste or route of administration can determine whether a treatment succeeds or fails. What is benign in one patient can be toxic in another, and what is theoretically effective may be completely unrealistic at home.